DalsnaFinance › Analyst accuracy › Canaccord Genuity › ABBV target

Canaccord Genuity’s $290 target on ABBV

ABBV AbbVie
$245 → $290 (+18%) by Aug 2027
raises · said Aug 3, 2026 · 12-month default horizon
Open: judged on the close on Aug 3, 2027

The article this target came from

ABBV Maintained by Canaccord Genuity -- Price Target Raised to $290

GuruFocus · Aug 3, 2026
ABBV Maintained by Canaccord Genuity -- Price Target Raised to $290

A fact about what Canaccord Genuity published, as reported by GuruFocus, not a recommendation from Dalsna Finance; Canaccord Genuity is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.